NO994041D0 - Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasöytiske forbindelser inneholdende dem - Google Patents

Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasöytiske forbindelser inneholdende dem

Info

Publication number
NO994041D0
NO994041D0 NO994041A NO994041A NO994041D0 NO 994041 D0 NO994041 D0 NO 994041D0 NO 994041 A NO994041 A NO 994041A NO 994041 A NO994041 A NO 994041A NO 994041 D0 NO994041 D0 NO 994041D0
Authority
NO
Norway
Prior art keywords
compounds
alkyl
treating
trihaloalkyl
heterocycle
Prior art date
Application number
NO994041A
Other languages
English (en)
Other versions
NO317516B1 (no
NO994041L (no
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Adrian Newman-Tancredi
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO994041D0 publication Critical patent/NO994041D0/no
Publication of NO994041L publication Critical patent/NO994041L/no
Publication of NO317516B1 publication Critical patent/NO317516B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO19994041A 1998-08-21 1999-08-20 Nye indan-l-ol forbindelser, en fremgangsmate for a behandle dem og farmasoytiske forbindelser inneholdende dem NO317516B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810601A FR2782515B1 (fr) 1998-08-21 1998-08-21 NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (3)

Publication Number Publication Date
NO994041D0 true NO994041D0 (no) 1999-08-20
NO994041L NO994041L (no) 2000-02-22
NO317516B1 NO317516B1 (no) 2004-11-08

Family

ID=9529811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994041A NO317516B1 (no) 1998-08-21 1999-08-20 Nye indan-l-ol forbindelser, en fremgangsmate for a behandle dem og farmasoytiske forbindelser inneholdende dem

Country Status (19)

Country Link
US (1) US6153625A (no)
EP (1) EP0982305B1 (no)
JP (1) JP2000072748A (no)
CN (1) CN1128144C (no)
AT (1) ATE214064T1 (no)
AU (1) AU747494B2 (no)
BR (1) BR9903867A (no)
CA (1) CA2280596A1 (no)
DE (1) DE69900961T2 (no)
DK (1) DK0982305T3 (no)
ES (1) ES2172294T3 (no)
FR (1) FR2782515B1 (no)
HK (1) HK1026212A1 (no)
HU (1) HUP9902784A3 (no)
NO (1) NO317516B1 (no)
NZ (1) NZ337362A (no)
PL (1) PL194852B1 (no)
PT (1) PT982305E (no)
ZA (1) ZA995321B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206512A (pt) * 2001-01-16 2004-01-06 Astrazeneca Ab Composto, método de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de um composto, e, processo para preparar um composto.
SE0103647D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chromone compounds
EP1353914A2 (en) * 2001-01-16 2003-10-22 AstraZeneca AB Therapeutic chromone compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
CN100384833C (zh) * 2001-01-16 2008-04-30 阿斯特拉曾尼卡有限公司 治疗用苯并二氢吡喃化合物
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CN1128144C (zh) 2003-11-19
AU747494B2 (en) 2002-05-16
EP0982305B1 (fr) 2002-03-06
JP2000072748A (ja) 2000-03-07
AU4463799A (en) 2000-03-09
NZ337362A (en) 2000-04-28
ATE214064T1 (de) 2002-03-15
CA2280596A1 (fr) 2000-02-21
EP0982305A1 (fr) 2000-03-01
PL194852B1 (pl) 2007-07-31
NO317516B1 (no) 2004-11-08
PT982305E (pt) 2002-07-31
DE69900961T2 (de) 2002-11-07
DK0982305T3 (da) 2002-06-24
CN1250051A (zh) 2000-04-12
US6153625A (en) 2000-11-28
HUP9902784A2 (hu) 2000-12-28
HUP9902784A3 (en) 2001-03-28
PL335012A1 (en) 2000-02-28
FR2782515B1 (fr) 2000-09-22
HU9902784D0 (en) 1999-10-28
NO994041L (no) 2000-02-22
ES2172294T3 (es) 2002-09-16
DE69900961D1 (de) 2002-04-11
FR2782515A1 (fr) 2000-02-25
ZA995321B (en) 2000-02-22
BR9903867A (pt) 2000-09-05
HK1026212A1 (en) 2000-12-08

Similar Documents

Publication Publication Date Title
SE9903998D0 (sv) New compounds
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
DE60235019D1 (de) Benzothiazepin-derivate für die behandlung von hyperlipidemia
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
ATE433447T1 (de) Pyrimiidinverbindungen
SE9903760D0 (sv) New compounds
NZ511927A (en) Phenylglycine derivatives
ATE484495T1 (de) Fungizide
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
DE60220525D1 (de) Pyrazolo-pyridine für die behandlung von herpes-ansteckungen
ES2243579T3 (es) Derivados de pirazolopirideno.
PL376324A1 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
HUP0203054A2 (hu) Farnezil protein transzferáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE9903997D0 (sv) New compounds
NO994041D0 (no) Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasöytiske forbindelser inneholdende dem
SE9804212D0 (sv) Compounds
NZ545580A (en) Aminoquinoline derivatives and their use as adenosine A3 ligands
HUP9902199A1 (hu) Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
ATE274515T1 (de) Pyrazolopyridinderivate
HUP0000966A2 (hu) Izoflavonszármazékok és ilyen vegyületeket hatóanyagként tartalmazó gyógyszerkészítmények